Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Rocket Pharmaceuticals (RCKT) operate in?

Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rocket Pharmaceuticals Stock (NASDAQ: RCKT) stock price, news, charts, stock research, profile.

Open	$19.00
Close	$21.53
Volume / Avg.	4.00M / 722.05K
Day Range	18.60 - 21.60
52 Wk Range	14.89 - 32.53
Market Cap	$1.92B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	21.71%
Days to Cover	14.5

Recent News

FDA Rejects Rocket Pharmaceuticals' Gene Therapy For Rare Immune Disorder, Asks For More Data, Stock Slides

Rocket Pharmaceuticals shares fell after the FDA issued a Complete Response Letter for Kresladi, a gene therapy for severe leukocyte adhesion deficiency-I. The FDA requested additional CMC information.

Vandana Singh

Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Avi Kapoor

Rocket Pharmaceuticals Upgraded to Buy: Here's Why

Investors might want to bet on Rocket Pharmaceuticals (NASDAQ: RCKT), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Rocket Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the developme...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Rocket Pharmaceuticals (RCKT) stock?

You can purchase shares of Rocket Pharmaceuticals (NASDAQ:RCKT) through any online brokerage.

View our list of the best stock brokerages

Who are Rocket Pharmaceuticals (RCKT) competitors?

Other companies in Rocket Pharmaceuticals’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Protagonist Therapeutics (NASDAQ:PTGX), Agios Pharmaceuticals (NASDAQ:AGIO), Apogee Therapeutics (NASDAQ:APGE) and Novavax (NASDAQ:NVAX).

What is the target price for Rocket Pharmaceuticals (RCKT) stock?

There is no analysis for Rocket Pharmaceuticals.

What is the forecast for Rocket Pharmaceuticals (RCKT) stock?

Rocket Pharmaceuticals has a consensus price target of $48.63.

Current stock price for Rocket Pharmaceuticals (RCKT)?

The stock price for Rocket Pharmaceuticals (NASDAQ: RCKT) is $21.1 last updated June 28, 2024 at 4:38 PM EDT.

Does Rocket Pharmaceuticals (RCKT) pay a dividend?

There are no upcoming dividends for Rocket Pharmaceuticals.

When is Rocket Pharmaceuticals (NASDAQ:RCKT) reporting earnings?

Rocket Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Rocket Pharmaceuticals (RCKT) going to split?

There is no upcoming split for Rocket Pharmaceuticals.

What sector and industry does Rocket Pharmaceuticals (RCKT) operate in?

Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Rocket Pharmaceuticals

Rocket Pharmaceuticals (RCKT) Forecast